Nvidia unveiled its Cosmos 3 Edge AI model on Wednesday, designed for robots and vision AI agents to perceive and navigate physical environments in real time. The announcement came during CEO Jensen Huang's two-day visit to Japan, where the company is forming a coalition with local industrial giants including Fujitsu, Hitachi, and Kawasaki Heavy Industries. The move deepens Nvidia's push into Japan's physical AI market, which is expected to reach $27.9 billion by 2029 according to the International Trade Administration, driven by Tokyo's active promotion of AI adoption across industries and local firms' eagerness to forge international partnerships.
Nvidia Launches Cosmos 3 Edge Model for Physical AI
Cosmos 3 Edge is a world model designed to help systems perceive and navigate physical environments in real time. World models are systems that can learn from a wider range of inputs compared to large language models (LLMs). The rollout follows the launch of Cosmos 3 in May.
"The next frontier of AI is in the physical world, and this is a once-in-a-generation opportunity for Japan," Nvidia CEO Jensen Huang said in a Wednesday statement. "Japan invented modern manufacturing. Now, it has the opportunity to reinvent it for the age of intelligent industries."
Nvidia Forms Coalition with Japanese Industrial Giants
The regional expansion takes center stage during Huang's two-day visit to Japan. Local industrial giants including Fujitsu, Hitachi, and Kawasaki Heavy Industries intend to join the coalition, according to Nvidia.
The partnership comes months after Microsoft's $10 billion investment in the country, which aims to build out AI infrastructure and beef up cybersecurity. Japanese investment giant SoftBank has bet heavily on the boom in AI, looking to partner with Microsoft and Sakura Internet to develop AI in Japan.
Nvidia Expands Healthcare and Biotech AI Initiatives in Japan
Nvidia is extending its reach into agentic AI for advanced sciences through new drug discovery and medical robotics initiatives. The company highlighted the ongoing expansion of Tokyo-1, the AI drug discovery consortium operated by Xeureka, a Mitsui subsidiary. The platform, which has steadily grown since its initial announcement in 2023, is powered by the Nvidia BioNeMo Agent Toolkit, a platform for accelerating autonomous AI drug discovery.
Japan's pharmaceutical heavyweights are already scaling their involvement. Major drugmakers including Astellas Pharma Inc, Daiichi Sankyo, and Ono Pharmaceutical are utilizing Nvidia's specialized biology toolkit to streamline their workflows, the U.S. company said in a blog post.
Beyond biotech, Nvidia said it is making inroads into industrial automation through a partnership with Kawasaki Heavy Industries.
Japan AI Market Growth Attracts U.S. Investment
Japan's AI market is expected to reach $27.9 billion by 2029, opening doors for U.S. firms to invest, according to the International Trade Administration. This growth is driven by Tokyo's active push to promote AI adoption across industries, coupled with the eagerness of local firms to forge international partnerships.
Ajay Rajadhyaksha, global chairman of research at Barclays, told CNBC last month that the country holds an advantage in Asia, driven by its diverse AI and clean structural growth stories.
FAQ
What did Nvidia unveil on Wednesday in Japan?
Nvidia unveiled its Cosmos 3 Edge AI model on Wednesday, designed for robots and vision AI agents to perceive and navigate physical environments in real time. The announcement came during CEO Jensen Huang's two-day visit to Japan.
Which Japanese companies are joining Nvidia's coalition?
Local industrial giants including Fujitsu, Hitachi, and Kawasaki Heavy Industries intend to join Nvidia's coalition, according to the company.
How are Japanese pharmaceutical companies using Nvidia's technology?
Major drugmakers including Astellas Pharma Inc, Daiichi Sankyo, and Ono Pharmaceutical are utilizing Nvidia's specialized biology toolkit to streamline their workflows through the Tokyo-1 AI drug discovery consortium operated by Xeureka, a Mitsui subsidiary.
